Lactate acidosis and simultaneous recruitment of TGF-β leads to alter plasticity of hypoxic cancer cells in tumor microenvironment.

[1]  Manjari Singh,et al.  Hypoxia induced lactate acidosis modulates tumor microenvironment and lipid reprogramming to sustain the cancer cell survival , 2023, Frontiers in Oncology.

[2]  Ibrahim M Dighriri,et al.  Efficacy and Safety of Luspatercept in the Treatment of β-Thalassemia: A Systematic Review , 2022, Cureus.

[3]  Hongmei Zhou,et al.  TGF-β signaling in the tumor metabolic microenvironment and targeted therapies , 2022, Journal of Hematology & Oncology.

[4]  Dangxia Zhou,et al.  Homeobox B9 Promotes the Progression of Hepatocellular Carcinoma via TGF-β1/Smad and ERK1/2 Signaling Pathways , 2022, BioMed research international.

[5]  Honggang Zhou,et al.  PKM2 promotes pulmonary fibrosis by stabilizing TGF-β1 receptor I and enhancing TGF-β1 signaling , 2022, Science advances.

[6]  Ryan J. K. Goh,et al.  Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint , 2022, EBioMedicine.

[7]  I. Melero,et al.  Cancer vaccines: the next immunotherapy frontier , 2022, Nature Cancer.

[8]  Wei Wang,et al.  TGF-β Enhances Immunosuppression of Myeloid-Derived Suppressor Cells to Induce Transplant Immune Tolerance Through Affecting Arg-1 Expression , 2022, Frontiers in Immunology.

[9]  Willy Hugo,et al.  The roles of TGF-β and VEGF pathways in the suppression of antitumor immunity in melanoma and other solid tumors , 2022, Pharmacology & therapeutics.

[10]  C. Heldin,et al.  Extracellular Vesicles and Transforming Growth Factor β Signaling in Cancer , 2022, Frontiers in Cell and Developmental Biology.

[11]  Jibo He,et al.  Acetyl-CoA Carboxylases and Diseases , 2022, Frontiers in Oncology.

[12]  M. D. King,et al.  Fortilin interacts with TGF-β1 and prevents TGF-β receptor activation , 2022, Communications Biology.

[13]  J. Nemunaitis,et al.  Pilot Study of Combination Gemogenovatucel-T (Vigil) and Durvalumab in Women With Relapsed BRCA-wt Triple-Negative Breast or Ovarian Cancer , 2022, Clinical Medicine Insights. Oncology.

[14]  Manjari Singh,et al.  Repurposing Combination Therapy of Voacamine With Vincristine for Downregulation of Hypoxia-Inducible Factor-1α/Fatty Acid Synthase Co-axis and Prolyl Hydroxylase-2 Activation in ER+ Mammary Neoplasia , 2021, Frontiers in Cell and Developmental Biology.

[15]  S. Park,et al.  Reducing tumor invasiveness by ramucirumab and TGF‐β receptor kinase inhibitor in a diffuse‐type gastric cancer patient‐derived cell model , 2021, Cancer medicine.

[16]  T. Blackwell,et al.  Adenosine/TGFβ axis in regulation of mammary fibroblast functions , 2021, PloS one.

[17]  A. Friedman,et al.  TGF-β inhibition can overcome cancer primary resistance to PD-1 blockade: A mathematical model , 2021, PloS one.

[18]  B. Monk,et al.  Proof of principle study of sequential combination atezolizumab and Vigil in relapsed ovarian cancer , 2021, Cancer Gene Therapy.

[19]  David J. Chen,et al.  Nonclinical Development of SRK-181: An Anti-Latent TGFβ1 Monoclonal Antibody for the Treatment of Locally Advanced or Metastatic Solid Tumors , 2021, International journal of toxicology.

[20]  A. Viola,et al.  TGF-β in Cancer: Metabolic Driver of the Tolerogenic Crosstalk in the Tumor Microenvironment , 2021, Cancers.

[21]  Jiang Ren,et al.  Targeting TGFβ signal transduction for cancer therapy , 2021, Signal Transduction and Targeted Therapy.

[22]  Ho-Jae Lee.  Recent Advances in the Development of TGF-β Signaling Inhibitors for Anticancer Therapy , 2020, Journal of cancer prevention.

[23]  T. Hu,et al.  Recent progress in TGF-β inhibitors for cancer therapy. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[24]  W. Fiedler,et al.  Transforming growth factor beta type 1 (TGF-β) and hypoxia-inducible factor 1 (HIF-1) transcription complex as master regulators of the immunosuppressive protein galectin-9 expression in human cancer and embryonic cells , 2020, Aging.

[25]  B. Monk,et al.  Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial. , 2020, The Lancet. Oncology.

[26]  A. Hakimi,et al.  TGF-β suppresses type 2 immunity to cancer , 2020, Nature.

[27]  T. Ahmed,et al.  1451P Comparative response evaluation of cisplatin-capecitabine with cisplatin-5-fluorouracil in advanced gastric carcinoma: A quasi-experimental study , 2020 .

[28]  L. Hawke,et al.  The Production of Pro-angiogenic VEGF-A Isoforms by Hypoxic Human NK Cells Is Independent of Their TGF-β-Mediated Conversion to an ILC1-Like Phenotype , 2020, Frontiers in Immunology.

[29]  Yangjinming Bai,et al.  The Post-translational Modifications of Smurf2 in TGF-β Signaling , 2020, Frontiers in Molecular Biosciences.

[30]  K. Miyazono,et al.  Targeting all transforming growth factor-β isoforms with an Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer , 2020, The Journal of Biological Chemistry.

[31]  Kyung-Chul Choi,et al.  A New TGF-β1 Inhibitor, CTI-82, Antagonizes Epithelial–Mesenchymal Transition through Inhibition of Phospho-SMAD2/3 and Phospho-ERK , 2020, Biology.

[32]  O. Feron,et al.  Acidosis-Induced TGF-β2 Production Promotes Lipid Droplet Formation in Dendritic Cells and Alters Their Potential to Support Anti-Mesothelioma T Cell Response , 2020, Cancers.

[33]  M. Fares,et al.  Molecular principles of metastasis: a hallmark of cancer revisited , 2020, Signal Transduction and Targeted Therapy.

[34]  J. Schlom,et al.  Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances , 2020, Journal for ImmunoTherapy of Cancer.

[35]  W. Han,et al.  TGFβ inhibition via CRISPR promotes the long-term efficacy of CAR-T cells against solid tumors. , 2020, JCI insight.

[36]  C. Dessy,et al.  TGFβ2-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells , 2020, Nature Communications.

[37]  G. Brooks,et al.  Is Lactate an Oncometabolite? Evidence Supporting a Role for Lactate in the Regulation of Transcriptional Activity of Cancer-Related Genes in MCF7 Breast Cancer Cells , 2020, Frontiers in Oncology.

[38]  V. Ganapathy,et al.  Lactate/GPR81 signaling and proton motive force in cancer: Role in angiogenesis, immune escape, nutrition, and Warburg phenomenon. , 2019, Pharmacology & therapeutics.

[39]  M. Delorenzi,et al.  Neutrophils suppress tumor‐infiltrating T cells in colon cancer via matrix metalloproteinase‐mediated activation of TGFβ , 2019, EMBO molecular medicine.

[40]  Y. Sakai,et al.  Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment , 2019, International journal of molecular sciences.

[41]  A. Steinle,et al.  Impairment of NKG2D-Mediated Tumor Immunity by TGF-β , 2019, Front. Immunol..

[42]  Chafen Lu,et al.  LRRC33 is a novel binding and potential regulating protein of TGF-β1 function in human acute myeloid leukemia cells , 2019, PloS one.

[43]  Hiroshi I. Suzuki,et al.  TGF-β Signaling in Cellular Senescence and Aging-Related Pathology , 2019, International journal of molecular sciences.

[44]  C. Hess,et al.  Tumor-derived TGF-β inhibits mitochondrial respiration to suppress IFN-γ production by human CD4+ T cells , 2019, Science Signaling.

[45]  J. Cheong,et al.  VEGF-C induced by TGF- β1 signaling in gastric cancer enhances tumor-induced lymphangiogenesis , 2019, BMC Cancer.

[46]  C. Nusbaum,et al.  TGFβ signaling underlies hematopoietic dysfunction and bone marrow failure in Shwachman-Diamond Syndrome. , 2019, The Journal of clinical investigation.

[47]  Chao Zeng,et al.  Exosomal Leucine-Rich-Alpha2-Glycoprotein 1 Derived from Non-Small-Cell Lung Cancer Cells Promotes Angiogenesis via TGF-β Signal Pathway , 2019, Molecular therapy oncolytics.

[48]  B. Ljungberg,et al.  Interactions between TGF-β type I receptor and hypoxia-inducible factor-α mediates a synergistic crosstalk leading to poor prognosis for patients with clear cell renal cell carcinoma , 2019, Cell cycle.

[49]  A. Nebreda,et al.  Regulation of tumor angiogenesis and mesenchymal–endothelial transition by p38α through TGF-β and JNK signaling , 2019, Nature Communications.

[50]  A. Avan,et al.  Therapeutic potential of pharmacological TGF-β signaling pathway inhibitors in the pathogenesis of breast cancer. , 2019, Biochemical pharmacology.

[51]  Eduard Batlle,et al.  Transforming Growth Factor-β Signaling in Immunity and Cancer. , 2019, Immunity.

[52]  X. Cui,et al.  Oxidized ATM-mediated glycolysis enhancement in breast cancer-associated fibroblasts contributes to tumor invasion through lactate as metabolic coupling , 2019, EBioMedicine.

[53]  X. Xiong,et al.  BAMBI regulates macrophages inducing the differentiation of Treg through the TGF-β pathway in chronic obstructive pulmonary disease , 2019, Respiratory Research.

[54]  H. Harada,et al.  HIF-1-Dependent Reprogramming of Glucose Metabolic Pathway of Cancer Cells and Its Therapeutic Significance , 2019, International journal of molecular sciences.

[55]  M. Blank,et al.  Smurfs in Protein Homeostasis, Signaling, and Cancer , 2018, Front. Oncol..

[56]  Changjiang Qin,et al.  Sauchinone prevents TGF-β-induced EMT and metastasis in gastric cancer cells. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[57]  Jing Ma,et al.  TGF‐β transactivates EGFR and facilitates breast cancer migration and invasion through canonical Smad3 and ERK/Sp1 signaling pathways , 2018, Molecular oncology.

[58]  R. Bourgon,et al.  TGF-β attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells , 2018, Nature.

[59]  U. Settmacher,et al.  TGF-β1-induced cell migration in pancreatic carcinoma cells is RAC1 and NOX4-dependent and requires RAC1 and NOX4-dependent activation of p38 MAPK. , 2017, Oncology reports.

[60]  G. Manda,et al.  Metabolic Pathways of the Warburg Effect in Health and Disease: Perspectives of Choice, Chain or Chance , 2017, International journal of molecular sciences.

[61]  O. Feron,et al.  Tumour acidosis: from the passenger to the driver's seat , 2017, Nature Reviews Cancer.

[62]  Junfa Li,et al.  TGF-β participates choroid neovascularization through Smad2/3-VEGF/TNF-α signaling in mice with Laser-induced wet age-related macular degeneration , 2017, Scientific Reports.

[63]  Xiaoping Yang,et al.  Interleukin 37 promotes angiogenesis through TGF-β signaling , 2017, Scientific Reports.

[64]  Ming O. Li,et al.  Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection. , 2017, Cold Spring Harbor perspectives in biology.

[65]  Ajay K. Singh,et al.  A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis , 2017, Kidney international reports.

[66]  J. Erler,et al.  Dynamics of cancerous tissue correlates with invasiveness , 2017, Scientific Reports.

[67]  N. Senzer,et al.  Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer. , 2016, Gynecologic oncology.

[68]  A. Bullock,et al.  Structural Basis of Intracellular TGF-β Signaling: Receptors and Smads. , 2016, Cold Spring Harbor perspectives in biology.

[69]  A. Pinto,et al.  Acidosis Drives the Reprogramming of Fatty Acid Metabolism in Cancer Cells through Changes in Mitochondrial and Histone Acetylation. , 2016, Cell metabolism.

[70]  Yu Liang,et al.  Conditional ablation of TGF-β signaling inhibits tumor progression and invasion in an induced mouse bladder cancer model , 2016, Scientific Reports.

[71]  V. Syed,et al.  TGF‐β Signaling in Cancer , 2016, Journal of cellular biochemistry.

[72]  W. Bloch,et al.  Natural Killer Cells—An Epigenetic Perspective of Development and Regulation , 2016, International journal of molecular sciences.

[73]  J. Lim,et al.  Dehydropeptidase 1 promotes metastasis through regulation of E-cadherin expression in colon cancer , 2016, Oncotarget.

[74]  Abdel Kareem Azab,et al.  The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy , 2015, Hypoxia.

[75]  C. Park,et al.  Breast cancer metastasis suppressor 1 (BRMS1) attenuates TGF-β1-induced breast cancer cell aggressiveness through downregulating HIF-1α expression , 2015, BMC Cancer.

[76]  S. Estrem,et al.  Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway , 2015, Drug design, development and therapy.

[77]  J. Seoane,et al.  USP15 regulates SMURF2 kinetics through C-lobe mediated deubiquitination , 2015, Scientific Reports.

[78]  M. Weller,et al.  Modulation of cerebral endothelial cell function by TGF-β in glioblastoma: VEGF-dependent angiogenesis versus endothelial mesenchymal transition , 2015, Oncotarget.

[79]  P. Leung,et al.  TGF-β1 Up-Regulates Connective Tissue Growth Factor Expression in Human Granulosa Cells through Smad and ERK1/2 Signaling Pathways , 2015, PloS one.

[80]  D. Sundar,et al.  HIF-inducible miR-191 promotes migration in breast cancer through complex regulation of TGFβ-signaling in hypoxic microenvironment. , 2015, Scientific Reports.

[81]  D. Szukiewicz,et al.  Review Article Transforming Growth Factor Beta Family: Insight into the Role of Growth Factors in Regulation of Fracture Healing Biology and Potential Clinical Applications , 2022 .

[82]  P. Papageorgis,et al.  Role of TGFβ in regulation of the tumor microenvironment and drug delivery (Review) , 2015, International journal of oncology.

[83]  P. Kongtawelert,et al.  Excessive Hyaluronan Production Promotes Acquisition of Cancer Stem Cell Signatures through the Coordinated Regulation of Twist and the Transforming Growth Factor β (TGF-β)-Snail Signaling Axis*♦ , 2014, The Journal of Biological Chemistry.

[84]  V. Kuchroo,et al.  TGF-β Signaling Initiated in Dendritic Cells Instructs Suppressive Effects on Th17 Differentiation at the Site of Neuroinflammation , 2014, PloS one.

[85]  Boris Pasche,et al.  TGF-β: duality of function between tumor prevention and carcinogenesis. , 2014, Journal of the National Cancer Institute.

[86]  C. Lottaz,et al.  Lactate-Modulated Induction of THBS-1 Activates Transforming Growth Factor (TGF)-beta2 and Migration of Glioma Cells In Vitro , 2013, PloS one.

[87]  O. Lee,et al.  Hypoxia-Induced Secretion of TGF-β1 in Mesenchymal Stem Cell Promotes Breast Cancer Cell Progression , 2013, Cell transplantation.

[88]  Tao-Tao Liu,et al.  Intratumor Hypoxia Promotes Immune Tolerance by Inducing Regulatory T Cells via TGF-β1 in Gastric Cancer , 2013, PloS one.

[89]  Jing Wang,et al.  TGF-Beta Suppresses VEGFA-Mediated Angiogenesis in Colon Cancer Metastasis , 2013, PloS one.

[90]  A. Mauviel,et al.  Overlapping activities of TGF-β and Hedgehog signaling in cancer: therapeutic targets for cancer treatment. , 2013, Pharmacology & therapeutics.

[91]  R. Derynck,et al.  TGF-β family signaling in stem cells. , 2013, Biochimica et biophysica acta.

[92]  J. Myklebust,et al.  SARA is dispensable for functional TGF‐β signaling , 2012, FEBS letters.

[93]  H. Ford,et al.  Molecular Pathways Molecular Pathways : Targeting the TGF-b Pathway for Cancer Therapy , 2012 .

[94]  Fei Huang,et al.  Regulation of TGF-β receptor activity , 2012, Cell & Bioscience.

[95]  Michael L. Gatza,et al.  Type III TGF-β receptor enhances colon cancer cell migration and anchorage-independent growth. , 2011, Neoplasia.

[96]  Yuguang Shi,et al.  SNX25 regulates TGF-β signaling by enhancing the receptor degradation. , 2011, Cellular signalling.

[97]  Z. Werb,et al.  Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.

[98]  Christopher J. Parsons,et al.  Inhibition of transforming growth factor‐β/Smad signaling improves regeneration of small‐for‐size rat liver grafts , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[99]  P. Howe,et al.  The tale of transforming growth factor‐beta (TGFβ) signaling: A soigné enigma , 2009, IUBMB life.

[100]  Julien Verrax,et al.  Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. , 2008, The Journal of clinical investigation.

[101]  Y. Inoue,et al.  Regulation of TGF‐β family signaling by E3 ubiquitin ligases , 2008, Cancer science.

[102]  L. Boon,et al.  Cutting Edge: Autocrine TGF-β Sustains Default Tolerogenesis by IDO-Competent Dendritic Cells1 , 2008, The Journal of Immunology.

[103]  P. Dijke,et al.  Negative regulation of TGF-β receptor/Smad signal transduction , 2007 .

[104]  M. Hu,et al.  Role of the Akt/FoxO3a pathway in TGF-beta1-mediated mesangial cell dysfunction: a novel mechanism related to diabetic kidney disease. , 2006, Journal of the American Society of Nephrology : JASN.

[105]  D. Rodríguez‐Puyol,et al.  Nitric Oxide Regulates Transforming Growth Factor-&bgr; Signaling in Endothelial Cells , 2005 .

[106]  J. Massagué,et al.  TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. , 2005, Cancer cell.

[107]  L. Attisano,et al.  Regulation of the TGFβ signalling pathway by ubiquitin-mediated degradation , 2004, Oncogene.

[108]  Hong Zhang,et al.  Cellular response to hypoxia involves signaling via Smad proteins. , 2003, Blood.

[109]  C. Heldin,et al.  Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. , 2002, Immunology letters.

[110]  M. Saruta,et al.  Clinical Potential of Oligonucleotide Therapeutics against Pancreatic Cancer , 2019 .

[111]  X. Liu,et al.  The contribution of TGF-β in Epithelial-Mesenchymal Transition (EMT): Down-regulation of E-cadherin via snail. , 2015, Neoplasma.

[112]  M. Shibuya,et al.  Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. , 2013, Journal of biochemistry.

[113]  A. Moustakas,et al.  Regulating the stability of TGFβ receptors and Smads , 2009, Cell Research.

[114]  Ye-Guang Chen.  Endocytic regulation of TGF-β signaling , 2009, Cell Research.

[115]  C. Savage-Dunn,et al.  TGF-β signaling * , 2006 .

[116]  H. Moses,et al.  Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. , 2001, Molecular biology of the cell.